Cis-pyro

   
Google
 
Web NewDrugInformation.com

Cis-pyro


Drug - Cis-pyro
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Technetium Tc-99m Pyrophosphate Kit
Multiple ingredients are in alphabetical order.

Strength - N/A
The potency of the active ingredient(s), Technetium Tc-99m Pyrophosphate Kit. May repeat for multiple part products.

Applicant - CIS
The firm name holding legal responsibility for Cis-pyro. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019039
The FDA assigned number to Cis-pyro. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Cis-pyro. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 30, 1987
The date Cis-pyro was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cis-pyro. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cis-pyro is in. Format is RX, OTC, DISCN.

Applicant Full Name - Cis Us Inc
The full name of the firm holding legal responsibility for the new application of Cis-pyro.

Cis-pyro